400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2020-09-09
Recursion Pharmaceuticals Inc
临床阶段生物药物研发商
医药研发/制造
化学&生物药
Samsara BioCapital;
Samsara BioCapital;
Catalio Capital Management;
Catalio Capital Management;
DCVC Bio;
Lux Capital;
Leaps by Bayer;
Casdin Capital;
EPIC Ventures;
Laurion Capital Management;
Intermountain Ventures;
Obvious Ventures;
Advantage Capital;
Felicis Ventures;
Baillie Gifford;
Mubadala;
Two Sigma Ventures
2019-07-15
Recursion Pharmaceuticals Inc
临床阶段生物药物研发商
医药研发/制造
化学&生物药
Lux Capital;
Lux Capital;
AME Cloud Ventures;
AME Cloud Ventures;
EPIC Ventures;
Obvious Ventures;
CRV;
Data Collective VC;
The University of Texas System;
University of Minnesota;
Felicis Ventures;
Mubadala;
Scottish Mortgage Investment Trust;
Intermountain Healthcare Innovation Fund;
Menlo;
Two Sigma Ventures
2017-10-04
Recursion Pharmaceuticals Inc
临床阶段生物药物研发商
医药研发/制造
化学&生物药
Lux Capital;
Lux Capital;
EPIC Ventures;
EPIC Ventures;
Mubadala;
Obvious Ventures;
CRV;
Advantage Capital;
Data Collective VC;
Felicis Ventures;
Menlo;
Two Sigma Ventures
2016-11-22
Recursion Pharmaceuticals Inc
临床阶段生物药物研发商
医药研发/制造
化学&生物药
Lux Capital;
Lux Capital;
AME Cloud Ventures;
AME Cloud Ventures;
EPIC Ventures;
Obvious Ventures;
Felicis Ventures;
Data Collective VC
2016-10-03
Recursion Pharmaceuticals Inc
临床阶段生物药物研发商
医药研发/制造
化学&生物药
Lux Capital;
Lux Capital;
AME Cloud Ventures;
AME Cloud Ventures;
EPIC Ventures;
Obvious Ventures;
Wild Basin Investments;
Data Collective VC
中国农药工业协会2026-01-26
经纬创投2026-01-26
GMP办公室2026-01-26
功能与专用化学品2026-01-26
一度医药2026-01-26
细胞与基因治疗领域2026-01-26
同写意2026-01-26
CIO合规保证组织2026-01-26
德联资本2026-01-26
生物安全情报网2026-01-26